Farinati F - Search Results

1

Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma.

Giannini EG, Moscatelli A, Pellegatta G, Vitale A, Farinati F, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Sacco R, Morisco F, Missale G, Foschi FG, Gasbarrini A, Baroni GS, Virdone R, Masotto A, Trevisani F; Italian Liver Cancer (ITA.LI.CA) Group; Italian Liver Cancer ITA LI CA Group. Giannini EG, et al. Among authors: farinati f. Am J Gastroenterol. 2016 Jan;111(1):70-7. doi: 10.1038/ajg.2015.389. Epub 2016 Jan 5. Am J Gastroenterol. 2016. PMID: 26729544

2

Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma.

Farinati F, De Maria N, Fornasiero A, Salvagnini M, Fagiuoli S, Chiaramonte M, Naccarato R. Farinati F, et al. Dig Dis Sci. 1992 May;37(5):659-62. doi: 10.1007/BF01296419. Dig Dis Sci. 1992. PMID: 1373360 Clinical Trial.

3

Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifen.

Farinati F, Salvagnini M, de Maria N, Fornasiero A, Chiaramonte M, Rossaro L, Naccarato R. Farinati F, et al. J Hepatol. 1990 Nov;11(3):297-301. doi: 10.1016/0168-8278(90)90211-9. J Hepatol. 1990. PMID: 1705274 Clinical Trial.

4

Diagnostic and prognostic value of the determination of the aminopropeptide of type III procollagen in patients with primary liver cancer.

Farinati F, Annoni G, Donato MF, Nardelli P, Bertozzo A, De Maria N, Zotti S, Salvagnini M, Martinez D, Naccarato R. Farinati F, et al. J Gastroenterol Hepatol. 1990 Nov-Dec;5(6):633-8. doi: 10.1111/j.1440-1746.1990.tb01117.x. J Gastroenterol Hepatol. 1990. PMID: 1966598

5

Hepatocellular carcinoma in primary biliary cirrhosis.

Farinati F, Floreani A, De Maria N, Fagiuoli S, Naccarato R, Chiaramonte M. Farinati F, et al. J Hepatol. 1994 Sep;21(3):315-6. doi: 10.1016/s0168-8278(05)80307-1. J Hepatol. 1994. PMID: 7530737

6

CCL4-induced liver cirrhosis and hepatocellular carcinoma in rats: relationship to plasma zinc, copper and estradiol levels.

Frezza EE, Gerunda GE, Farinati F, DeMaria N, Galligioni A, Plebani F, Giacomin A, Van Thiel DH. Frezza EE, et al. Among authors: farinati f. Hepatogastroenterology. 1994 Aug;41(4):367-9. Hepatogastroenterology. 1994. PMID: 7959573

7

Tamoxifen treatment in hepatocellular carcinoma.

Farinati F. Farinati F. Gastroenterology. 1996 Jul;111(1):272-4. doi: 10.1053/gast.1996.v111.agast961110272. Gastroenterology. 1996. PMID: 8698220 No abstract available.

8

Fine-needle biopsy in focal liver lesions: the usefulness of a screening programme and the role of cytology and microhistology.

Herszenyi L, Farinati F, Cecchetto A, Marafin C, de Maria N, Cardin R, Naccarato R. Herszenyi L, et al. Among authors: farinati f. Ital J Gastroenterol. 1995 Dec;27(9):473-8. Ital J Gastroenterol. 1995. PMID: 8919314

9

Activation of cytotoxic and natural killer T-cell system in patients with hepatocellular carcinoma and cirrhosis.

Marafin C, Rinaldi M, Angonese C, De Franchis G, Plebani M, Naccarato R, Farinati F. Marafin C, et al. Among authors: farinati f. Ital J Gastroenterol. 1996 Dec;28(9):493-8. Ital J Gastroenterol. 1996. PMID: 9131393

10

How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.

Farinati F, Rinaldi M, Gianni S, Naccarato R. Farinati F, et al. Cancer. 2000 Dec 1;89(11):2266-73. Cancer. 2000. PMID: 11147597

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

404 results

Search Page